XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Cash $ 186,873 $ 618,537
Prepaid expenses 123,039 159,510
Deposits 750 750
Total Current Assets 310,662 778,797
Property, plant and equipment, net 197,336 199,695
Right to use asset 41,991 8,001
Investment in P & S, Inc. 78,000
Total Assets 549,989 1,064,493
Current Liabilities    
Accounts payable and accrued expense 350,785 287,089
Convertible notes payable, net of discounts of $13,425 and $17,935, respectively 31,575 33,065
Convertible notes payable, related parties, net of discounts of $24,431 and $57,413, respectively 86,169 19,787
Convertible notes payable, in default 308,300 328,300
Convertible notes payable, in default - related parties 527,900 399,700
Notes payable, in default 130,000 175,000
Notes payable, in default - related parties 18,500 18,500
Shareholder loan 1,500 1,500
Lease liability, current 14,680 8,079
Total Current Liabilities 1,469,409 1,271,020
Lease liability, long-term 27,594
Total Liabilities 1,497,003 1,271,020
Stockholders' Deficit    
Common stock, $0.0001 par value - 9,900,000,000 shares authorized; 5,315,683,905 and 4,761,162,383 shares issued and outstanding at December 31, 2020 and 2019 , repectively 530,315 474,863
Common stock to be issued, $0.0001 par value, 1,500,000 and 11,620,000 shares outstanding at December 31, 2020 and 2019, respectively 150 1,162
Unearned compensation 67,058
Additional paid-in capital 18,514,376 16,581,432
Accumulated deficit (19,924,797) (17,263,984)
Total Stockholders' Deficit (947,014) (206,527)
Total Liabilities and Stockholders' Deficit 549,989 1,064,493
Series A    
Stockholders' Deficit    
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding at December 31, 2020 and 2019; Series B - 60 shares issued and outstanding at December 31, 2020 and 2019
Series B    
Stockholders' Deficit    
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding at December 31, 2020 and 2019; Series B - 60 shares issued and outstanding at December 31, 2020 and 2019